Literature DB >> 2381655

Side effects of the use of botulinum toxin for treatment of benign essential blepharospasm and hemifacial spasm.

H K Kalra1, E H Magoon.   

Abstract

From April 1983 to April 1988, 381 botulinum toxin injections for lid spasms were administered to 106 patients. Sixty-nine had bilateral blepharospasm and 37 had hemifacial spasm. Of the 381 injections, 308 had been given to patients who returned for follow-up examinations. No systemic effects were noted at any of these visits; all side effects were temporary; there were no serious complications. Ptosis, the most frequently encountered problem, occurred after 26 (8.4%) of the injections. Other complications included: corneal exposure (after eight injections, 2.59%); face droop (after 11 injections, 3.57%); diplopia (after five injections, 1.62%); and subtle visual blurring (after eight injections, 2.59%). One patient noted jaw tenseness, another mentioned tearing, one reported brow droop, and another complained of crossed eyes. Ten injections had minimal effect; in these cases a repeat injection usually was effective. Only four patients chose surgery after beginning injections. We conclude that botulinum toxin injections are a safe, effective means of treating lid spasms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2381655

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  8 in total

1.  Low-dose botulinum toxin a for treatment of blepharospasm and hemifacial spasm.

Authors:  Anuchit Poonyathalang; Pisit Preechawat; Uraiwan Jamnansiri
Journal:  Jpn J Ophthalmol       Date:  2005 Jul-Aug       Impact factor: 2.447

2.  Localised autonomic failure due to botulinum toxin injection.

Authors:  K O Bushara
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-07       Impact factor: 10.154

Review 3.  Hemifacial spasm: a prospective long-term follow up of 83 cases treated by microvascular decompression at two neurosurgical centres in the United Kingdom.

Authors:  R D Illingworth; D G Porter; J Jakubowski
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

4.  Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm.

Authors:  Ren-Wen Ho; Po-Chiung Fang; Tsai-Ling Chao; Chun-Chih Chien; Ming-Tse Kuo
Journal:  Sci Rep       Date:  2018-05-30       Impact factor: 4.379

Review 5.  A Review of Periocular Botulinum Neurotoxin on the Tear Film Homeostasis and the Ocular Surface Change.

Authors:  Ren-Wen Ho; Po-Chiung Fang; Cheng-Hsien Chang; Yu-Peng Liu; Ming-Tse Kuo
Journal:  Toxins (Basel)       Date:  2019-01-24       Impact factor: 4.546

Review 6.  Botulinum Toxin in Movement Disorders: An Update.

Authors:  Charenya Anandan; Joseph Jankovic
Journal:  Toxins (Basel)       Date:  2021-01-08       Impact factor: 4.546

Review 7.  The whole truth about botulinum toxin - a review.

Authors:  Henryk Witmanowski; Katarzyna Błochowiak
Journal:  Postepy Dermatol Alergol       Date:  2019-02-05       Impact factor: 1.837

Review 8.  Emerging opportunities for serotypes of botulinum neurotoxins.

Authors:  Zhongxing Peng Chen; J Glenn Morris; Ramon L Rodriguez; Aparna Wagle Shukla; John Tapia-Núñez; Michael S Okun
Journal:  Toxins (Basel)       Date:  2012-11-07       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.